Search - tctmd.com

Displaying 1 - 20 of 86

Sort: Relevancy | Date

News Daily News

FDA Passes on Inclisiran, Citing Manufacturing Site Problems

December 23, 2020

Cost-effectiveness Favors Anatomic Over Functional Testing for Stable Chest Pain

News Daily News

Cost-effectiveness Favors Anatomic Over Functional Testing for Stable Chest Pain

December 18, 2020

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

News Daily News

AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More

December 17, 2020

Routine Use of GRACE Score Doesn’t Improve ACS Management: AGRIS

News Daily News

Routine Use of GRACE Score Doesn’t Improve ACS Management: AGRIS

December 16, 2020

Inclisiran Approved in Europe for Lowering LDL Cholesterol

News Daily News

Inclisiran Approved in Europe for Lowering LDL Cholesterol

Michael O'Riordan

December 11, 2020

In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition

News Daily News

In ISCHEMIA, Stable CAD Treatment Effect Hinged on MI Definition

Michael O'Riordan

December 11, 2020

Increased ASCVD Risk With Inflammatory Bowel Disease Merits Team-Based Care

News Daily News

Increased ASCVD Risk With Inflammatory Bowel Disease Merits Team-Based Care

December 08, 2020

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

News Daily News

Subjective Statin-Related AEs Have Been Rising; Hard Proof, Not So Much

Michael O'Riordan

November 26, 2020

Type 2 MI Patients Often Miss Out on Seeing a Cardiologist

News Daily News

Type 2 MI Patients Often Miss Out on Seeing a Cardiologist

November 23, 2020

CTA Doesn’t Add Value in At-Risk Patients Thought to Have ACS

News Conference News AHA 2020

CTA Doesn’t Add Value in At-Risk Patients Thought to Have ACS

November 20, 2020

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

News Conference News AHA 2020

No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk

Michael O'Riordan

November 19, 2020

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

News Conference News AHA 2020

Both Statins and Placebos Produce ‘Very Real’ Side Effects: SAMSON

Michael O'Riordan

November 15, 2020

OMEMI: Omega-3 Fatty Acids No Help in Elderly MI Patients

News Conference News AHA 2020

OMEMI: Omega-3 Fatty Acids No Help in Elderly MI Patients

November 15, 2020

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

News Conference News AHA 2020

Clopidogrel Should Remain Antiplatelet of Choice in Elective PCI: ALPHEUS

Michael O'Riordan

November 14, 2020

SCAPIS: CTA Finds Silent CAD in 42% of Middle-aged Adults

News Conference News AHA 2020

SCAPIS: CTA Finds Silent CAD in 42% of Middle-aged Adults

November 13, 2020

One Pill to Treat Them All: Polycap Strategy Sees Success in TIPS-3

News Conference News AHA 2020

One Pill to Treat Them All: Polycap Strategy Sees Success in TIPS-3

Michael O'Riordan

November 13, 2020

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

News Conference News AHA 2020

Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol

Michael O'Riordan

November 12, 2020

Coronary Calcium Scans May ID Patients Who Benefit From Aspirin

News Daily News

Coronary Calcium Scans May ID Patients Who Benefit From Aspirin

Michael O'Riordan

October 30, 2020

Superiority of Ticagrelor Over Clopidogrel in ACS Questioned

News Daily News

Superiority of Ticagrelor Over Clopidogrel in ACS Questioned

October 29, 2020

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

News Conference News TCT 2020

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

October 21, 2020

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.